Tag Archives: Merck

No Indian pharma company features in world’s top 20 companies trying to make medicines affordable

New Delhi: Not even a single Indian pharmaceutical company features in the list of world’s top 20 companies that have attempted at making medicines affordable for those in low and middle income countries, revealed a recent study by the Netherlands-based Access to Medicine Foundation.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , , , , , , | Leave a comment

Integration of oncology with traditional treatment procedures driving the market worldwide

Progress and technological advancement in the field of medical science have created several opportunities in the field of oncology and oncology drugs.

Posted in OPINIONS | Tagged , , , , , , , | 1 Comment

New drug combination may improve outcomes for women with advanced breast cancer when administered before surgery

New Orleans (US): Results from the I-SPY 2 trial show that giving patients with HER2-positive invasive breast cancer a combination of the drugs trastuzumab emtansine (T-DM1) and pertuzumab before surgery was more beneficial than the combination of paclitaxel plus trastuzumab.

Posted in Oncology, RESEARCH | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

How India tackles adverse drug reactions — by ignoring data

With 10 percent of 3.63 trillion medicines popped worldwide in 2015, India is the world’s third-largest medicine market. It stands to scientific reason that these drugs will have side effects.

Posted in FEATURES | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

US FDA approves Bridion to reverse effects of neuromuscular blocking drugs used during surgery

Washington: The US Food and Drug Administration on Monday approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , , , , | Leave a comment

Maharashtra governor’s wake-up call to tackle ‘lifestyle diseases’

Mumbai: Maharashtra Governor C V Rao on Saturday asked the Indian pharmaceutical industry to develop drugs for lifestyle diseases like diabetes, hypertension, cardiovascular ailments and tuberculosis, among others.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

US FDA expands approved use of Opdivo in advanced lung cancer

Washington: The US Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , | Leave a comment

High Court restrains Glenmark from selling anti-diabetes drugs

New Delhi: The Delhi High Court on Wednesday restrained Mumbai-based Glenmark Pharmaceuticals Ltd from making or selling its generic anti-diabetes drugs Zita and Zita-Met while holding it infringing patent of a US drug maker Merck, Sharp and Dohme Corporation.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , | Leave a comment

US FDA approves Keytruda for advanced non-small cell lung cancer

Washington: The US Food and Drug Administration on Friday granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumours that express a protein called PD-L1.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , | Leave a comment

Cancer drug spending tops $100 billion globally: Report

New York (IANS): Total global spending on cancer medicines — including therapeutic treatments and supportive care — have reached the $100-billion threshold in 2014, says a report.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , | Leave a comment